The bulk of this article seems to be concerned with potential privacy implications of widespread sequencing of patients. Which is a worthwhile topic, but not wh

The bulk of this article seems to be concerned with potential privacy implications of widespread sequencing of patients. Which is a worthwhile topic, but not what you might expect from its headline. Some of the scenarios seem tired to me, like the idea that insurers might penalize you for having increased odds of expensive conditions (already against the law in the US; also, why not imagine that they would give most of their customers discounts for not having those risks?)